Cytotoxic T cells recognize mosaic structures consisting of target peptides embedded within self-major histocompatibility complex (MH) class I molecules. This structure has been described in great detail for several peptide-MHC complexes. In contrast, how T-cell receptors recognize peptide-MHC complexes have been less well characterized. We have used a complete set of singly substituted analogs of a mouse MHC class I, Kk-restricted peptide, influenza hemagglutinin (Ha)25s.262, to address the binding specificity of this MHC molecule. Using the same peptide-MHC complexes we determined the fine specificity of two Ha255.262-specific, Kk-restricted T cells, and of a unique antibody, pSAN, specific for the same peptide-MHC complex.
T cells. Thus, the majority, and perhaps all, of the side chains of the non-primary anchor residues may be available for T-cell recognition, and contribute to the stringent specificity of T cells. A striking similarity between the specificity of the T cells and that of the pSAN antibody was found and most of the peptide residues, which could be recognized by the T cells, could also be recognized by the antibody.
Eradicating infected cells is an important strategy in the defense against intracellular pathogens. One of the cell types involved, the CD8+ cytotoxic T cells (CTLs), has developed a unique and quite elaborate mode of recognition: only antigens, which are presented in association with class I molecules of the major histocompatibility complex (MHC), are recognized (1) . The function of MHC class I molecules is to sample peptides derived from the cytosolic protein environment of the target cell (reviewed in ref. 2) . The MHC specifically selects some of these peptides, transports them to the target cell surface where they are presented to CD8+ CTLs. Although additional accessory molecules are involved in the activation of T cells, the final antigen-specific event is thought to be the creation of multimeric complexes consisting of T-cell receptors (TcR) and peptide-MHC class I complexes (3) .
MHC class I molecules are highly polymorphic heterodimers that consist of a transmembrane heavy chain and a noncovalently associated soluble light chain, the 132-microglobulin (4) . The majority of the polymorphism is concentrated in the membrane distal domains of the heavy chain, a, and a2, which form a unique peptide-binding structure (5) (6) (7) (8) . X-ray crystallography has revealed this target structure to be a collage in which the peptide is deeply buried within the MHC. This leaves only a minority of the peptide residues, scattered and intermingled with MHC residues, available for T-cell recognition (reviewed in ref. 9) . The specificity of peptide-MHC interactions has been described in great detail, whereas little biochemical (10) (11) (12) (13) (14) or structural (15, 16 ) data exist on T-cell recognition. It is generally assumed that self-MHC accounts for the majority of the T-cell target structure, whereas antigenic peptides constitute a smaller, albeit highly heterogeneous portion of this structure (8, 17) . The peptide is at the center of the MHC target structure (5) , and it is assumed that this is appositioned by the most diverse part of the TcR, the CDR3 regions (17) . Further assuming that the TcR structure bears some resemblance to antibody structures, models have placed the CDR3 regions in the center of the TcR (17) . Structural data support this model (16) . Thus, the core regions of the peptide-MHC and the TcR structures are thought to align to afford an extensive surface overlap, but the orientation of the TcR relative to the MHC is controversial (12, 18) .
We have used a complete set of singly substituted analogs of a CTL epitope to examine the fine specificity of the mouse MHC class I molecule, Kk. Independently, we have generated a model of the peptide-MHC complex. Furthermore, we have examined the fine specificity of two T cells specific for this particular peptide-MHC complex and examined the fine specificity of a unique antibody specific for the same peptide-MHC complex. The TcR and the antibody appeared to recognize almost identical target structures, with peptide contributions being donated by all by non-primary anchor residues.
MATERIALS AND METHODS Cells. The AKR (H-2k)-derived T-cell lymphoma, RDM-4, was used for production of Kk (19, 20) . The influenza (ATCC VR100) hemagglutinin (Ha)25s262 (FESTGNLI, single-letter amino acid code)-specific, Kk-restricted T-cell hybridomas, HK8.3-5H3 and HK8.3-6F8 have been described (21) .
Antibodies. The monoclonal antibody 11-4-1 [anti a1-2 Kk, (22) ] was produced as ascites and purified by protein-A Sepharose (Pharmacia) affinity chromatography. The generation of the Ha255-262-specific, Kk-restricted recombinant Fab antibody fragment, pSAN13.4.1, has been described (23) .
Peptides. A complete (except cysteine) set of single substituted analog peptides was synthesized for the Ha255-262 (FEST-GNLI) epitope by standard fluorenylmethoxycarbonyl (Fmoc) protection strategy using a multi-peptide synthesizer (24) .
MHC Purification, Peptide-MHC Binding, MHC Specificity. Kk molecules were affinity-purified from lysates of RDM-4 using 11-4-1 coupled to cyanogen bromide-activated Sepharose 4B as the affinity matrix (20) . To determine the specificity Abbreviations: MHC, major histocompatibility complex; TcR, T-cell receptor; IL-2, interleukin 2; CTL, cytotoxic T cells.
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of the Kk molecule we used a biochemical peptide-MHC binding assay (25 found for positions 1, 5, and 7, where F appeared to be preferred in position 1, charged amino acids and Y to be disfavored in position 5, and F and L to be preferred in position 7.
T-Cell Recognition of the Kk-Restricted Ha25s262 Epitope.
To examine the fine specificity of MHC class I restricted T-cell responses, the stimulatory capacities of each of the single amino acid substituted analogs were determined in a bioassay using the two Ha255-262 specific, Kk-restricted T-cell hybridomas, HK8.3-6F8 (Fig. iB) and HK8.3-5H3 (Fig. 1C) . It should be noted that this assay depends on both Kk binding and T-cell recognition. A dose-response analysis was made for each analog and used to determine the concentration of analog needed to stimulate a response of 100 units/ml of IL-2. The most critical peptide residues were F in position 1 (both hybridomas), T in position 4 (both hybridomas), and N in position 6 (HK8.3-6F8). In these positions, the T-cell specificities were very stringent as only the parental amino acids were accepted; any substitution led to a complete loss of stimulatory activity (except for the conservative substitution of T --S in position 4, which led to a 10-fold loss). Considerable, but less stringent, specificity was observed for position 3 (both hybridomas), position 6 (HK8.3-5H3), and position 7 (both hybridomas). Only a few substitutions, mostly conservative or semi-conservative, were allowed in these positions. A slightly more promiscuous specificity was observed for position 5 (both hybridomas). Finally, the least critical peptide residues were the anchor positions for Kk: I in position 8 (both hybridomas) followed by E in position 2 (both hybridomas). Several substitutions were more or less accepted in these positions, and many of the substitutions, which led to a loss of T-cell stimulatory activity, could be accounted for by loss in Kk binding.
Recognition of the Kk-Restricted Ha25-262 Epitope by a "T cell like" Antibody. We have recently generated a recombinant antibody, pSAN13.4.1, with a rather unique specificity (23) . It recognizes complexes consisting of Ha255-262 and Kk in a way that appears reminiscent of a peptide-specific, MHC-restricted T-cell specificity. To further investigate this point, the pSAN13.4.1-binding capacity of each of the single amino acid substituted analogs was determined in a biochemical assay in which soluble analog-Kk complexes were used to inhibit the binding of pSAN13.4.1 to immobilized Ha255-262-Kk complexes. The analog-Kk complexes were generated under peptide-saturating conditions to minimize the influence of Kk specificity and focus on the specificity of pSAN13.4.1. The most critical residue was T in position 4, which could only be replaced with the conservative substitution, S. The second most critical residues were L in position 7 and S in position 3, where some substitutions, mostly conservative to semiconservative, were accepted (Fig. 1D) . Less critical was F in position 1, which could be replaced by about 10 substitutions mostly conservative or semi-conservative leading to less than a 10-fold loss in binding. In contrast, the less critical residues were G in position 5 and E in position 2, which could be replaced by 13 or 14 amino acids. Finally, the least critical residue was I in position 8, which could be replaced with any other amino acid (except R). (Fig. 2 A vs. B) . The Kk molecule has a deep hydrophobic invagination at the location within the cleft, which is responsible for binding the side chain of the C-terminal amino acid of the peptide. This pocket is almost identical in shape and chemical nature to the equivalent pocket in the Kb molecule, explaining the similar binding capacities of the two molecules in the class of the C-terminal anchor selected. However, the deep pocket in the Kb molecule, which sequesters the central P5 anchor of Kb binding peptides, is completely occluded in the Kk molecule, where the P5 glycine "side chain" rests on a plateau in the center of the cleft. This suggests that side chains of P5 of Kk binding peptides either face outward, or if facing downward into Kk side, are limited to only the smallest amino acids, such as glycine and alanine. (E) and 8 (I) as anchor residues (28, 29) . Subsequently, we investigated the specificity of two Ha2ss-262-specific, Kk_ restricted T-cell hybridomas. The vast majority of the single substitutions ('70%) completely destroyed the epitope as seen by both hybridomas, "20% led to a pronounced, albeit not complete, loss of stimulation and only -10% led to less than a 10-fold loss in stimulatory capacity. In accordance with previous observations on T-cell specificity (30) (31) (32) (33) , the present hybridomas exhibited an exquisite specificity as most singly substitutions, even conservative ones, were detectable; the few more or less acceptable substitutions tended to be conservative: E -> D, S -> A, T S-> , G -* A, L -> I/V, etc. The two T hybridomas had largely overlapping specificities; however, there were also distinct differences between the two (e.g., D and G in position 2; E, G, M, Q in position 3; several amino acids in position 6; P and V in position 7). The most important positions in shaping the T-cell specificity were readily identified as positions 1, 4, and 6 where very few, if any, substitutions were allowed. Slightly less important were positions 3 and 7 followed by the intermediary position 5. Position 8 was clearly the least important residue in defining the T-cell specificity, and taking the requirement for Kk interaction into account, position 2 did not appear important either. These data would suggest that the TcRs interact with the specific side chains of the residues corresponding to positions 1, 4, and 6, thus requiring absolute amino acid identity at these positions. Less stringent requirements are placed upon positions 3 and 7, which could be explained by the T-cell receptor crossreacting with a few (mostly structurally similar) side chains. The lack of specificity corresponding to positions 8, 2, and 5 could be due to the TcR not interacting with these side chains, or interacting with the peptide backbone (i.e., no requirement for amino acid identity). In terms of availability, our data would suggest that the side chains of positions 1, 4, and 6 are accessible to the receptors, pointing out of the peptide binding cleft, or at least sideways. The side chains of positions 3 and 7 are also to some extent accessible. The side chains of positions 8 and 2 are inaccessible, most likely because they point into the MHC, in accord with their assignment as primary anchors. Note that the assignment of positions 1, 4, and 6/7 as T-cell interacting positions correspond as a mirror image to the assignment of positions 2 and 8 (and to some extent 5) as MHC interacting positions, so that recognition of the same amino acids by both TcR and MHC class I does not appear to occur, at least not for these hybridomas. In contrast, one of us (S.B.) has previously suggested such corecognition in a mouse MHC class II system (30) .
We generated pSAN13.4.1 through recombinant technology involving selection from a phage-display library (23) . The specificity of pSAN13.4.1 resembled that of Ha25s5262-specific, Kk-restricted T cells because it only recognized Ha255262 in the context of Kk and, furthermore, resulted in specific and potent inhibition of specific T-cell responses. Now we have examined the fine specificity of pSAN13.4.1 and compared it to the specificity of two T-cell responses. As illustrated in Fig. 1 , a striking similarity was found between the specificities of the two TcRs and that of pSAN13.4.1. Thus, the Ha255-262 positions 4 and 7, followed by positions 3 and 6, were recognized with high stringency by pSAN13. 4 A theoretical model of the Ha255-262-Kk complex was build independently of the experimental result. This model suggests that the peptide lies in an irregular extended conformation. The N terminus of the peptide is completely buried within the A pocket, but its phenylalanine side chain extends to the surface of the MHC, and may be seen obliquely from the direction of the a2-helix. The side chain of the glutamic acid residue in the anchoring position 2 is completely buried in the B pocket. The side chain of the serine in position 3 is pointing sideways and up towards the a2-helix of the MHC. The side chain of the threonine in position 4, in addition to leucine in position 7, point straight up and are the most accessible residues in the peptide, in keeping with the T-cell stimulation and pSAN13.4.1 recognition data. In contrast, the "side chain" of the glycine in position 5 is buried, laying upon a plateau that traverses the cleft of the Kk molecule, with the Ca carbon, the point of attachment for peptide side chains, facing downwards. The side chain of the asparagine in position 6 points sideways towards the a2-helix and is partially exposed permitting recognition by the TcR. Finally, the side chain of the isoleucine in position 8 is deeply embedded in the F pocket. The data on the recognition of the analogs by Kk show that two of the three peptide side chains, which the model suggests are pointing downwards, are actively involved in MHC interaction. Similarly, the data on the T-cell and pSAN13.4.1 recognitions demonstrate that all of the peptide side chains, which the model suggests are pointing upwards, are actively involved in TcR or pSAN13.4.1 interaction. These independent observations provides an excellent validation for the model of the Ha2s55262-Kk complex presented here.
The experimental results and the model contribute to our understanding of T-cell specificity and structure. Our data support the assumption that the structure of the TcR resembles that of an immunoglobulin Fab fragment (15) (16) (17) . Thus, the TcR would engage a surface area of '800 A2, much like the size and shape the Ha255-262-Kk complex as it is outlined in Fig.   3a . The peptide only contributes a minor proportion of the total ligand surface. This outward facing surface of the peptide-MHC complex appears quite flat with minor indentions notably between the a-helices and the peptide, leaving some of the sideways pointing residues accessible (Fig. 3 b-d) . Most of the peptide side chains did not extend above the plane of the a-helices. Nonetheless, the identity of these side chains can be detected by the TcRs, suggesting that the side chains of the variable loops of the TcR may interdigitate into the cleft and contact the semi-exposed side chains of the peptide. Recently, TcRs have been reported to recognize different core regions of the peptide-MHC complex, e.g., either centered around the N-or C-terminal part of the peptide (34) . In contrast, we find that both T cells recognize the peptide from the N terminal of the peptide and almost to the C terminal, and that the TcR must interact with the majority, if not all, of the available side chains. Thus, the TcR appears to make the most of the relatively minor contribution of the peptide to the overall ligand surface. As the majority of the TcR ligand is made up of self-MHC, maximizing the contribution of the peptide should make it easier for the T cells to distinguish between self and non-self. This feat, however, cannot be a simple one since T cells must be educated in the thymus through positive and negative selection processes to become self-MHC restricted, i.e., to exhibit a certain measure of self-reactivity, yet avoid excessive self-reactivity. In contrast, antibodies are not educated to be self-MHC restricted and consequently "T cell like" antibodies should be rare. In agreement, such antibodies have only been sporadically reported in the literature and we had to resort to the high-selection power of the phage display tech- responses. Evolutionary, the segregation between the two recognition modes may be more functionally than structurally determined.
